Lupron Depot-4

   
Google
 
Web NewDrugInformation.com

Lupron Depot-4


Drug - Lupron Depot-4
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Leuprolide Acetate
Multiple ingredients are in alphabetical order.

Strength - 30MG/VIAL
The potency of the active ingredient(s), Leuprolide Acetate. May repeat for multiple part products.

Applicant - TAP PHARM
The firm name holding legal responsibility for Lupron Depot-4. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020517
The FDA assigned number to Lupron Depot-4. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Lupron Depot-4. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 30, 1997
The date Lupron Depot-4 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Lupron Depot-4. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Lupron Depot-4 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Tap Pharmaceutical Products Inc
The full name of the firm holding legal responsibility for the new application of Lupron Depot-4.

Lupron Depot-4